
Concord Biotech gets FDA nod for immunosuppressant mycophenolate mofetil
Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and paediatric recipients aged three months and older of allogeneic…








